Skip to content

A PROSPECTIVE INTERVENTIONAL STUDY TO PREVENT GESTATIONAL DIABETES AMONG PREGNANT WOMEN FROM A TERTIARY CARE HOSPITAL IN CHENNAI

Prospective Interventional Study to Prevent Gestational Diabetes Among Pregnant Women in Tertiary Care centre at Chennai - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113410
Enrollment
1000
Registered
2026-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications

Interventions

Intervention1: Medication for PPBS less than 110: no medication Intervention2: Medication for PPBS range 110 to 119: Metformin 250 mg BD and check PPBS after weekly till 11 weeks and continue through

Sponsors

Madras medical college
Lead Sponsor
Dr Mahalakshmi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. All consenting pregnant women who are attending antenatal clinic at 8weeks of gestation at KGH whose PPBS value is 110mg/dl to 119 mg/dl 2. Mothers willing to adhere tosaid intervention i.e., Tab Metformin (prescribed dosage BD) along with Medical Nutrition Therapy

Exclusion criteria

Exclusion criteria: 1. Pregnant women less that 8 weeks of gestation 2. Multiple Gestation Pregnancy 3. Pregnant women whose first antenatal visit at more than 11 weeks of gestation 4. Mothers who are not willing to give consent. 5. Known case of Overt Diabetes 6. History of GDM in previous pregnancy 7. Mothers identified as Overt DM during the first visit 8.. Mothers whose PPBS value persistently beyond expected control ( >110mg/dl) during course of the study even with increased dosage of METFORMIN 9. Mothers who develop any adverse event to T. METFORMIN

Design outcomes

Primary

MeasureTime frame
Prevention of development of Gestational Diabetes among pregnant women by controlling blood glucose from 8 weeks of gestationTimepoint: 2 weeks, 4 weeks, 6 weeks, 8 weeks

Secondary

MeasureTime frame
Antenatal Postnatal follow up to identify mothers developing diabetes mellitusTimepoint: 6 months, 12 months, 18 months

Countries

India

Contacts

Public ContactSumathi C

Madras Medical College

directorkgh@gmail.com9884498977

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026